alosetron and tegaserod

alosetron has been researched along with tegaserod in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	30 (81.08)	29.6817
2010's	7 (18.92)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Shen, B; Soffer, E	1
Camilleri, M	3
Elsenbruch, S; Enck, P; Hollerbach, S	1
Talley, NJ	1
Delvaux, M; Frexinos, J	1
Drossman, DA; Longstreth, GF	1
Horwitz, BJ	1
Bjorkman, D; Brandt, LJ; Fennerty, MB; Locke, GR; Olden, K; Peterson, W; Quigley, E; Schoenfeld, P; Schuster, M; Talley, N	1
Chey, WD	1
Olden, KW	1
Cash, BD; Chey, WD	1
Mangel, AW	1
Lacy, BE	1
Johanson, JF	1
Jones, R; Kennedy, T; Rubin, G	1
Ehrenpreis, ED	1
Fedotov, E; Miftahof, R	1
Kamm, MA	1
Kuo, B; Podovei, M	1
Herszényi, L; Juhász, M; Miheller, P; Pregun, I; Tulassay, Z	1
Johnson, DA; Schiller, LR	1
Mayer, EA	1
Brandt, LJ; Chey, WD; Ford, AC; Foxx-Orenstein, AE; Moayyedi, P; Young, C	1
Holzer, P; Painsipp, E; Shahbazian, A	1
Saad, RJ	1
Lewis, JH	1
Ervin, CM; Mangel, AW	1
Bielefeldt, K	1
Dance, A	1
Morgan, B	1

Reviews

24 review(s) available for alosetron and tegaserod

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
The challenge of irritable bowel syndrome: creating an alliance between patient and physician. Cleveland Clinic journal of medicine, 2001, Volume: 68, Issue:3 Topics: Abdominal Pain; Antidepressive Agents; Antidiarrheals; Carbolines; Cholinergic Antagonists; Colonic Diseases, Functional; Constipation; Diagnosis, Differential; Diarrhea; Diet; Follow-Up Studies; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Indoles; Middle Aged; Parasympatholytics; Patient Education as Topic; Physician-Patient Relations; Psychotherapy; Randomized Controlled Trials as Topic; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors	2001
Novel medications for the irritable bowel syndrome: motility and sensation. Journal of pediatric gastroenterology and nutrition, 2001, Volume: 32 Suppl 1 Topics: Abdominal Pain; Animals; Carbolines; Colonic Diseases, Functional; Constipation; Female; Gastrointestinal Agents; Humans; Indoles; Male; Serotonin Antagonists; Serotonin Receptor Agonists; Sex Factors	2001
[Irritable bowel syndrome as an interdisciplinary clinical challenge. Current views on its pathophysiology, diagnosis and treatment]. Deutsche medizinische Wochenschrift (1946), 2001, Apr-20, Volume: 126, Issue:16 Topics: Adult; Carbolines; Clinical Trials as Topic; Colonic Diseases, Functional; Diagnosis, Differential; Diet; Female; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Indoles; Intestines; Male; Psychotherapy; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors	2001
Serotoninergic neuroenteric modulators. Lancet (London, England), 2001, Dec-15, Volume: 358, Issue:9298 Topics: Benzofurans; Carbolines; Clinical Trials as Topic; Colonic Diseases, Functional; Female; Humans; Indoles; Male; Serotonin Antagonists; Serotonin Receptor Agonists	2001
[Visceral sensitivity and functional bowel disorders: physiopathological role and therapeutic perspectives]. Gastroenterologie clinique et biologique, 2001, Volume: 25, Issue:2 Pt 2 Topics: Abdominal Pain; Animals; Benzyl Compounds; Carbolines; Central Nervous System; Colitis, Ulcerative; Colon; Colonic Diseases, Functional; Colonoscopy; Controlled Clinical Trials as Topic; Diarrhea; Digestion; Electromyography; Female; Follow-Up Studies; Gastric Emptying; Gastroenteritis; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Indoles; Intestines; Male; Myenteric Plexus; Neurons; Neurotransmitter Agents; Placebos; Pressure; Propylamines; Receptors, Opioid, kappa; Rectum; Risk Factors; Serotonin Antagonists; Serotonin Receptor Agonists; Sex Factors; Time Factors	2001
New developments in the diagnosis and treatment of irritable bowel syndrome. Current gastroenterology reports, 2002, Volume: 4, Issue:5 Topics: Anti-Bacterial Agents; Carbolines; Celiac Disease; Clinical Trials as Topic; Colonic Diseases, Functional; Diagnosis, Differential; Female; Forecasting; Gastrointestinal Agents; Humans; Indoles; Male; Prognosis; Risk Assessment; Severity of Illness Index	2002
Systematic review on the management of irritable bowel syndrome in North America. The American journal of gastroenterology, 2002, Volume: 97, Issue:11 Suppl Topics: Antidepressive Agents, Tricyclic; Antidiarrheals; Behavior Therapy; Carbolines; Cathartics; Colonic Diseases, Functional; Diagnosis, Differential; Humans; Indoles; Loperamide; North America; Parasympatholytics; Randomized Controlled Trials as Topic; Research Design; Serotonin Antagonists; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome	2002
Tegaserod and other serotonergic agents: what is the evidence? Reviews in gastroenterological disorders, 2003, Volume: 3 Suppl 2 Topics: Carbolines; Colonic Diseases, Functional; Humans; Indoles; Serotonin Antagonists; Serotonin Receptor Agonists	2003
Irritable bowel syndrome: an overview of diagnosis and pharmacologic treatment. Cleveland Clinic journal of medicine, 2003, Volume: 70 Suppl 2 Topics: Antidepressive Agents; Benzofurans; Carbazoles; Carbolines; Colonic Diseases, Functional; Gastrointestinal Agents; Humans; Indoles; Physical Examination; Pyridines	2003
Advances in the management of irritable bowel syndrome. Current gastroenterology reports, 2003, Volume: 5, Issue:6 Topics: Antidepressive Agents, Tricyclic; Carbolines; Cost of Illness; Desipramine; Evidence-Based Medicine; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Psychotherapy; Serotonin Antagonists; United States	2003
Advances in pharmacological treatments of IBS. Journal of pediatric gastroenterology and nutrition, 2004, Volume: 39 Suppl 3 Topics: Anti-Bacterial Agents; Benzyl Compounds; Carbolines; Clonidine; Humans; Indoles; Inflammatory Bowel Diseases; Neostigmine; Probiotics; Propylamines	2004
Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies. Neurogastroenterology and motility, 2004, Volume: 16, Issue:6 Topics: Animals; Antidepressive Agents; Antidiarrheals; Carbolines; Cathartics; Humans; Indoles; Intestines; Irritable Bowel Syndrome; Parasympatholytics; Serotonin; Serotonin Agents	2004
Irritable bowel syndrome. Clinical evidence, 2004, Issue:11 Topics: Adult; Aged; Antidepressive Agents; Carbolines; Dietary Fiber; Female; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Male; Middle Aged; Serotonin Antagonists; Serotonin Receptor Agonists	2004
Irritable bowel syndrome. 10% to 20% of older adults have symptoms consistent with diagnosis. Geriatrics, 2005, Volume: 60, Issue:1 Topics: Aged; Carbolines; Diagnosis, Differential; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Risk Factors	2005
Pharmacological treatment of irritable bowel syndrome--from concept to sales. The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 2002, Issue:587 Topics: Antidepressive Agents; Benzofurans; Carbolines; Cisapride; Constipation; Drug Industry; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Serotonin 5-HT3 Receptor Antagonists; Serotonin 5-HT4 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists	2002
Irritable bowel syndrome: a practical review. Southern medical journal, 2006, Volume: 99, Issue:11 Topics: Antidepressive Agents; Carbolines; Dietary Fiber; Food Hypersensitivity; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Indoles; Irritable Bowel Syndrome; Parasympatholytics; Prevalence; Retrospective Studies; Serotonin Antagonists; United States	2006
[Novel therapeutic approaches in the treatment of irritable bowel syndrome]. Orvosi hetilap, 2007, May-20, Volume: 148, Issue:20 Topics: Adrenergic alpha-Agonists; Analgesics, Opioid; Anti-Bacterial Agents; Antidepressive Agents; Carbolines; Chloride Channel Agonists; Cholecystokinin; Corticotropin-Releasing Hormone; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Muscarinic Antagonists; Neurokinin-1 Receptor Antagonists; Neurotrophin 3; Parasympatholytics; Probiotics; Receptors, Neurokinin-2; Serotonin Agents; Somatostatin	2007
Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications. Neurogastroenterology and motility, 2007, Volume: 19 Suppl 2 Topics: Appetite Depressants; Carbolines; Cyclobutanes; Dyspepsia; Gastrointestinal Agents; Genetic Variation; Humans; Indoles; Obesity; Pharmacogenetics; Polymorphism, Genetic; Receptors, Serotonin; Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists	2007
Clinical practice. Irritable bowel syndrome. The New England journal of medicine, 2008, Apr-17, Volume: 358, Issue:16 Topics: Adult; Antidepressive Agents, Tricyclic; Carbolines; Cognitive Behavioral Therapy; Desipramine; Female; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Male; Parasympatholytics; Practice Guidelines as Topic	2008
Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. The American journal of gastroenterology, 2009, Volume: 104, Issue:7 Topics: Adult; Age Factors; Aged; Carbazoles; Carbolines; Dose-Response Relationship, Drug; Drug Administration Schedule; Education, Medical, Continuing; Female; Humans; Indoles; Irritable Bowel Syndrome; Male; Middle Aged; Patient Satisfaction; Pyridines; Quality of Life; Randomized Controlled Trials as Topic; Risk Assessment; Serotonin Antagonists; Severity of Illness Index; Sex Factors; Treatment Outcome	2009
Peripherally acting therapies for the treatment of irritable bowel syndrome. Gastroenterology clinics of North America, 2011, Volume: 40, Issue:1 Topics: Alprostadil; Antidiarrheals; Carbolines; Dietary Fiber; Dietary Supplements; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Laxatives; Lubiprostone; Parasympatholytics; Serotonin Antagonists; Serotonin Receptor Agonists	2011
The risk of ischaemic colitis in irritable bowel syndrome patients treated with serotonergic therapies. Drug safety, 2011, Jul-01, Volume: 34, Issue:7 Topics: Animals; Carbolines; Colitis, Ischemic; Female; Humans; Indoles; Irritable Bowel Syndrome; Male; Serotonin 5-HT3 Receptor Antagonists; Serotonin 5-HT4 Receptor Agonists	2011
Clinical trials in irritable bowel syndrome: a review. Reviews on recent clinical trials, 2013, Volume: 8, Issue:1 Topics: Alprostadil; Benzamides; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carbolines; Dose-Response Relationship, Drug; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Lubiprostone; Peptides; Phenylalanine; Phloroglucinol; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin	2013

Other Studies

13 other study(ies) available for alosetron and tegaserod

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
New drugs to treat irritable bowel syndrome being tested. Mayo Clinic health letter (English ed.), 2000, Volume: 18, Issue:3 Topics: Benzofurans; Carbolines; Colonic Diseases, Functional; Female; Gastrointestinal Agents; Guanidines; Humans; Indoles; Male; Serotonin Antagonists	2000
FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky. Health news (Waltham, Mass.), 2002, Volume: 8, Issue:10 Topics: Carbolines; Colonic Diseases, Functional; Diagnosis, Differential; Drug Approval; Female; Gastrointestinal Agents; Humans; Indoles; Male; United States; United States Food and Drug Administration	2002
Evidence-based position statement on the management of irritable bowel syndrome in North America. The American journal of gastroenterology, 2002, Volume: 97, Issue:11 Suppl Topics: Antidepressive Agents, Tricyclic; Antidiarrheals; Behavior Therapy; Carbolines; Cathartics; Colonic Diseases, Functional; Diagnosis, Differential; Evidence-Based Medicine; Humans; Indoles; Loperamide; North America; Parasympatholytics; Randomized Controlled Trials as Topic; Serotonin Antagonists; Serotonin Receptor Agonists; Severity of Illness Index	2002
Study design issues in irritable bowel syndrome. Alimentary pharmacology & therapeutics, 2004, Jan-01, Volume: 19, Issue:1 Topics: Carbolines; Double-Blind Method; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Randomized Controlled Trials as Topic; Treatment Outcome	2004
New options for soothing an irritable bowel. The Johns Hopkins medical letter health after 50, 2004, Volume: 16, Issue:1 Topics: Carbolines; Diet; Dietary Fiber; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Probiotics; Psychotherapy; Serotonin Receptor Agonists	2004
Therapy for irritable bowel syndrome. The New England journal of medicine, 2004, Mar-18, Volume: 350, Issue:12 Topics: Carbolines; Humans; Indoles; Irritable Bowel Syndrome; Polypharmacy; Serotonin 5-HT3 Receptor Antagonists; Serotonin 5-HT4 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists	2004
Intestinal propulsion of a solid non-deformable bolus. Journal of theoretical biology, 2005, Jul-07, Volume: 235, Issue:1 Topics: Algorithms; Biomechanical Phenomena; Carbolines; Electrophysiology; Gastrointestinal Motility; Humans; Indoles; Intestines; Models, Biological; Muscle Contraction; Muscle, Smooth; Serotonin Antagonists; Serotonin Receptor Agonists	2005
Balancing drug risk and benefit: toward refining the process of FDA decisions affecting patient care. The American journal of gastroenterology, 2008, Volume: 103, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Carbolines; Clinical Trials as Topic; Drug Approval; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Male; Product Surveillance, Postmarketing; Risk; Serotonin Receptor Agonists; United States; United States Food and Drug Administration	2008
Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats. British journal of pharmacology, 2009, Volume: 158, Issue:5 Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Carbazoles; Carbolines; Clonidine; Colitis; Colon; Fasting; Female; Heart Rate; Indoles; Mesenteric Artery, Superior; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyridines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Serotonin 5-HT3 Receptor Antagonists; Serotonin 5-HT4 Receptor Antagonists; Splanchnic Circulation; Vasoconstrictor Agents; Vasodilator Agents	2009
Ischemic Colitis as a Complication of Medication Use: An Analysis of the Federal Adverse Event Reporting System. Digestive diseases and sciences, 2016, Volume: 61, Issue:9 Topics: Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antineoplastic Agents; Antipsychotic Agents; Autoimmune Diseases; Bone Density Conservation Agents; Carbolines; Colitis, Ischemic; Colonoscopy; Databases, Factual; Diphosphonates; Estrogens; Female; Gonadal Steroid Hormones; Humans; Immunosuppressive Agents; Indoles; Interferons; Irritable Bowel Syndrome; Laxatives; Male; Mental Disorders; Middle Aged; Neoplasms; Osteoporosis; Preoperative Care; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Sex Factors; Tryptamines; United States	2016
Transit time. Nature, 2016, 05-19, Volume: 533, Issue:7603 Topics: Anti-Bacterial Agents; Biofeedback, Psychology; Carbolines; Colitis; Diet; Dysentery; Dyspepsia; Egypt; Female; Firmicutes; Greece; Helicobacter pylori; History, 17th Century; History, 19th Century; History, 20th Century; History, 21st Century; History, Ancient; Humans; Indoles; Intestines; Irritable Bowel Syndrome; Marketing; NAV1.5 Voltage-Gated Sodium Channel; Penicillins; Phenethylamines; Practice Guidelines as Topic; Rifamycins; Rifaximin; Serotonin; Social Support; Spirit Possession	2016
Drug development: A healthy pipeline. Nature, 2016, 05-19, Volume: 533, Issue:7603 Topics: Animals; Benzimidazoles; Benzofurans; Bile Acids and Salts; Carbolines; Colesevelam Hydrochloride; Colestipol; Disease Models, Animal; Enteric Nervous System; Female; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Loperamide; Lubiprostone; Male; Mice; Natriuretic Peptides; Peptides; Phenylalanine; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Rifamycins; Rifaximin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Visceral Pain	2016